Leptin therapy in lipodystrophy

Diabetologia

Volumn 53, Issue 1, 2010, Pages 7-9

  Savage, D B ^a   O'Rahilly, S ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Diabetes; Fatty liver; Insulin resistance; Leptin; Lipodystrophy; Triacylglycerol

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; RECOMBINANT LEPTIN; TRIACYLGLYCEROL;

ADIPOSE TISSUE; AUTOIMMUNE DISEASE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; DRUG EFFICACY; DYSLIPIDEMIA; FATTY LIVER; GENE MUTATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; KIDNEY FUNCTION; LIPODYSTROPHY; LIPOPROTEIN BLOOD LEVEL; METABOLIC STRESS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NOTE; NUTRITIONAL STATUS; OBESITY; OPEN STUDY; PANCREATITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA; SIDE EFFECT; T CELL LYMPHOMA; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOSE TISSUE; DRUG TOLERANCE; EATING; FATTY ACIDS, NONESTERIFIED; HUMANS; LEPTIN; LIPODYSTROPHY; PROSPECTIVE STUDIES; TRIGLYCERIDES;

EID: 72449160044     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-009-1545-y     Document Type: Note

References (21)

1. KN Frayn 2002 Adipose tissue as a buffer for daily lipid flux Diabetologia 45 1201 1210 10.1007/s00125-002-0873-y 1:CAS:528: DC%2BD38XntFegur0%3D 12242452
2. S Cinti G Mitchell G Barbatelli, et al. 2005 Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans J Lipid Res 46 2347 2355 10.1194/jlr.M500294-JLR200 1:CAS:528:DC%2BD2MXhtF2iu7vF 16150820 (Pubitemid 41532523)
3. GS Hotamisligil 2006 Inflammation and metabolic disorders Nature 444 860 867 10.1038/nature05485 1:CAS:528:DC%2BD28XhtlShtrzK 17167474 (Pubitemid 46024993)
4. DB Savage KF Petersen GI Shulman 2007 Disordered lipid metabolism and the pathogenesis of insulin resistance Physiol Rev 87 507 520 10.1152/physrev. 00024.2006 1:CAS:528:DC%2BD2sXoslGmu7Y%3D 17429039 (Pubitemid 47084679)
5. A Garg 2000 Gender differences in the prevalence of metabolic complications in familial partial lipodystrophy (Dunnigan variety) J Clin Endocrinol Metab 85 1776 1782 10.1210/jc.85.5.1776 1:CAS:528: DC%2BD3cXlt1Wls74%3D 10843151 (Pubitemid 32269275)
6. O Gavrilova B Marcus-Samuels D Graham, et al. 2000 Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice J Clin Invest 105 271 278 10.1172/JCI7901 1:CAS:528:DC%2BD3cXhtVSlt7c%3D 10675352
7. MS Rodeheffer K Birsoy JM Friedman 2008 Identification of white adipocyte progenitor cells in vivo Cell 135 240 249 10.1016/j.cell.2008.09.036 1:CAS:528:DC%2BD1cXhtlWhsr%2FE 18835024
8. MA Pelleymounter MJ Cullen MB Baker, et al. 1995 Effects of the obese gene product on body weight regulation in ob/ob mice Science 269 540 543 10.1126/science.7624776 1:CAS:528:DyaK2MXntF2ktr4%3D 7624776
9. IS Farooqi SA Jebb G Langmack, et al. 1999 Effects of recombinant leptin therapy in a child with congenital leptin deficiency N Engl J Med 341 879 884 10.1056/NEJM199909163411204 1:STN:280:DyaK1MvgsVyrtA%3D%3D 10486419 (Pubitemid 29427050)
10. I Shimomura RE Hammer S Ikemoto MS Brown JL Goldstein 1999 Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy Nature 401 73 76 10.1038/43448 1:CAS:528:DyaK1MXlvVGmsLo%3D 10485707 (Pubitemid 29418444)
11. EA Oral V Simha E Ruiz, et al. 2002 Leptin-replacement therapy for lipodystrophy N Engl J Med 346 570 578 10.1056/NEJMoa012437 1:CAS:528: DC%2BD38XhsFKqu7c%3D 11856796 (Pubitemid 34438818)
12. JY Park ED Javor EK Cochran AM DePaoli P Gorden 2007 Long-term efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophy Metabolism 56 508 516 10.1016/j.metabol.2006.11.010 1:CAS:528:DC%2BD2sXjsVCjtrY%3D 17379009 (Pubitemid 46427848)
13. K Mulligan H Khatami JM Schwarz, et al. 2009 The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia J Clin Endocrinol Metab 94 1137 1144 10.1210/jc.2008-1588 1:CAS:528: DC%2BD1MXksFait7o%3D 19174500
14. AY Chong BC Lupsa EK Cochran P Gorden 2010 Efficacy of leptin therapy in the different forms of human lipodystrophy Diabetologia 10.1007/s00125-009-1502- 9
15. ED Javor SA Moran JR Young, et al. 2004 Proteinuric nephropathy in acquired and congenital generalized lipodystrophy: baseline characteristics and course during recombinant leptin therapy J Clin Endocrinol Metab 89 3199 3207 10.1210/jc.2003-032140 1:CAS:528:DC%2BD2cXlslegs78%3D 15240593 (Pubitemid 38951884)
16. IS Farooqi G Matarese GM Lord, et al. 2002 Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency J Clin Invest 110 1093 1103 1:CAS:528:DC%2BD38XotFGlurk%3D 12393845
17. X Prieur YC Tung JL Griffin IS Farooqi S O'Rahilly AP Coll 2008 Leptin regulates peripheral lipid metabolism primarily through central effects on food intake Endocrinology 149 5432 5439 10.1210/en.2008-0498 1:CAS:528: DC%2BD1cXhtlWnsrrE 18635658
18. GM Leinninger YH Jo RL Leshan, et al. 2009 Leptin acts via leptin receptor-expressing lateral hypothalamic neurons to modulate the mesolimbic dopamine system and suppress feeding Cell Metab 10 89 98 10.1016/j.cmet.2009.06. 011 1:CAS:528:DC%2BD1MXhsVChsLrP 19656487
19. KF Petersen EA Oral S Dufour, et al. 2002 Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy J Clin Invest 109 1345 1350 1:CAS:528:DC%2BD38XjvFCls7k%3D 12021250
20. DC Robbins E Danforth Jr ES Horton RL Burse RF Goldman EA Sims 1979 The effect of diet on thermogenesis in acquired lipodystrophy Metabolism 28 908 916 10.1016/0026-0495(79)90090-8 1:STN:280:DyaL3c%2FhtVyltg%3D%3D 481216
21. KM Utzschneider DL Trence 2006 Effectiveness of gastric bypass surgery in a patient with familial partial lipodystrophy Diabetes Care 29 1380 1382 10.2337/dc06-0130 16732025 (Pubitemid 44125939)